title: Primary prevention of type 2 diabetes: how do we do it?
authors.affiliation: Department of Diabetes, Lin Medical Center, Clalit Health Services, Haifa, Israel. muhammadab@clalit.org.il
authors.forename: Muhammad A
authors.initials: MA
authors.lastname: Abdul-Ghani
authors.forename: Muhammad
authors.initials: M
authors.lastname: Sabah
authors.forename: Oscar
authors.initials: O
authors.lastname: Minuchin
authors.forename: Pnina
authors.initials: P
authors.lastname: Vardi
authors.forename: Itamar
authors.initials: I
authors.lastname: Raz
authors.forename: Julio
authors.initials: J
authors.lastname: Wainstein
mesh_terms: D020909:Acarbose / Q000627:therapeutic use*; D001786:Blood Glucose; D003327:Coronary Disease / Q000209:etiology / Q000517:prevention & control; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008019:Life Style; D011322:Primary Prevention / Q000379:methods*; D015431:Weight Loss
chemical_list: D001786:Blood Glucose; D007004:Hypoglycemic Agents; D020909:Acarbose